PDCD1 and hepatitis A virus infection: Our meta-analysis showed that, compared with standard chemotherapy, PD-1/PD-L1 inhibitor monotherapy and PD-1/PD-L1 inhibitor plus chemotherapy significantly increased the risk of all-grade and high-grade hepatitis.